Immunoassay
The NEONATAL PAP Screening ELISA is an ELISA-type quantitative test that allows determination of the concentration of pancreatitis-associated protein (PAP) in newborns. This second-line test is used as part of screening for cystic fibrosis (CF) in neonates, from blood samples dried on 903® or 226 type blotting paper.
The NEONATAL PAP Screening ELISA is a sandwich ELISA assay: anti-PAP antibodies allow both capture of the pancreatitis-associated protein present in the sample in the well of the microplate and quantification by colorimetry. Thus, the measured absorbance signal intensity is proportional to the concentration of PAP in the sample. .
This second-line test contributes to the screening for cystic fibrosis in neonates
Product code :
The Immunomat™ is intended for neonatal screening laboratories performing between 400 and 1000 daily determinations. With a maximum capacity of 7 microplates, it optimizes the rate of the laboratory by allowing the processing of different parameters in parallel.
The NEONATAL IRT Screening ELISA is an ELISA-type quantitative test that allows determination of the concentration of human immunoreactive trypsinogen (IRT). This test is for newborn screening of cystic fibrosis (CF) from blood samples dried on 903® and 226 type blotting paper.